Finance

Lists
ONESOURCE:NSE
Onesource Specialty Pharma Ltd
₹1,578.20
+0.61%
(+9.50) 1D
Nov 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ONESOURCE...
Open
₹1,585.40
High
₹1,599.80
Low
₹1,566.00
Mkt. cap
181.46B
Avg. vol.
633.71K
Volume
481.45K
52-wk high
₹1,917.80
52-wk low
₹1,057.00
EPS
-₹0.15
No. of employees
2K
Open
₹1,585.40
High
₹1,599.80
Low
₹1,566.00
Mkt. cap
181.46B
Avg. vol.
633.71K
Volume
481.45K
52-wk high
₹1,917.80
52-wk low
₹1,057.00
EPS
-₹0.15
No. of employees
2K
News stories
From web sources and news partners
About Onesource Specialty Pharma Ltd
CEO-
Employees1.67K
Founded2007
Headquarters-
SectorHealth care
Industry-
Last report
Oct 27, 2026
Fiscal period
Q2 2027
₹5.16 / ₹4.70
+9.87%beat
Revenue / Est. (INR)
5.16B / 4.84B
+6.57%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.90B
4.30B
4.49B
5.16B
Cost of goods sold
943.66M
2.35B
1.42B
1.47B
Cost of revenue
943.66M
2.35B
1.42B
1.47B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
641.92M
749.51M
686.80M
775.80M
Operating expense
2.48B
2.04B
2.55B
2.81B
Total operating expenses
3.43B
4.39B
3.97B
4.28B
Operating income
-523.15M
-87.15M
516.01M
882.40M
Other non operating income
46.25M
-229.61M
38.02M
9.54M
EBT including unusual items
-930.11M
-2.92M
202.94M
528.65M
EBT excluding unusual items
-859.21M
-4.48M
245.94M
546.32M
Income tax expense
-43.12M
-48.89M
-47.03M
-46.19M
Effective tax rate
4.64%
1,674.32%
-23.17%
-8.74%
Other operating expenses
1.14B
572.91M
1.15B
1.28B
Net income
-886.99M
45.97M
249.97M
574.84M
Net profit margin
-30.55%
1.07%
5.57%
11.13%
Earnings per share
-7.15
-
2.56
5.16
Interest and investment income
-
115.54M
-
-
Interest expense
-382.31M
-117.67M
-308.09M
-345.62M
Net interest expenses
-382.31M
-2.13M
-308.09M
-345.62M
Depreciation and amortization charges
696.37M
718.26M
717.46M
750.51M
EBITDA
92.24M
540.71M
1.21B
1.62B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps